In July 2013, pharmaphorum filmed a round table debate, sponsored by AstraZeneca, to discuss the topic of 'Oncology shaping the future of personalised healthcare'.
Consumer DNA testing company 23andMe has signed a deal to acquire privately-held Lemonaid Health in a $400 million deal that marks a move into the online health sector.
An alarming number of people in England are being prescribed medicines unnecessarily, which could harm their health, according to a UK government review.
Watch the full round table video debate on 'oncology shaping the future of personalised healthcare', to see what our expert panel, with representation from pharma, diagnostics, physicians and p
In the third part of our video round table debate on how oncology is shaping the future of personalised healthcare, the expert panel focusses on the critical role that pharmaceutical companies
Biogen has scaled back its ambitions for Denali-partnered Parkinson’s disease candidate BIIB122, abandoning a complex and likely costly phase 3 trial that isn’t due to com
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas